visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    Ziopharm Oncology

    Get Full Access

    Description

    • ZIOPHARM Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing a portfolio of immuno-oncology therapies to treat patients with cancer. The company develops Sleeping Beauty platform, which is based on the non-viral genetic engineering of immune cells using a transposon/transposase system to engineer T-cells outside of the body for infusion; and Controlled IL-12 to stimulate expression of interleukin 12 or IL-12, a master regular of the immune system, in a controlled manner to focus the patient's immune system to attack cancer cells. Its product candidates include T cell receptor + T therapies to target solid tumors; chimeric antigen receptor + T cell therapies targeting CD19 for hematologic malignancies; and Ad-RTS-hIL-12 plus veledimex, a gene delivery system to regulate production of IL-12 to treat patients with recurrent glioblastoma multiforme in adults. The company has a license agreement with PGEN Therapeutics, Inc.; research and development agreement with The University of Texas MD Anderson Cancer Center; a patent license agreement with the National Cancer Institute; and a cooperative research and development agreement with the National Cancer Institute. ZIOPHARM Oncology, Inc. is headquartered in Boston, Massachusetts.
    • location

      Headquarters:1 First Avenue , Boston, Massachusetts, United States

      More
    • Ziopharm Oncology phone

      Phone Number: +1 617-259-1970

    • Ziopharm Oncology website

      Website: https://www.ziopharm.com

    • Ziopharm Oncology employees

      Employees:113

    • Ziopharm Oncology revenue

      Revenue:$10 - 50M

    • Ziopharm Oncology legal name

      Legal Name:Ziopharm Oncology

    • Ziopharm Oncology's Social Media

      Ziopharm Oncology linkedin Ziopharm Oncology facebook Ziopharm Oncology twitter
    • done Is this data correct?

    • |  NAICS Code: 541715  |

        NYSE: ZIOP

      Show More
    Person level website identification

    CEO for Ziopharm Oncology

    Kevin Boyle

    Chief Executive Officer

    Person level website visitor identification

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    Raffaele Baffa

    Head Research And Development And Chief Medical Officer, Executive Vice President

    Kevin Lafond

    Senior Vice President Finance, Chief Accounting Officer And Treasurer

    Haroon Hashmi

    Vice President, Regulatory Affairs

    John Amedio

    Vice President, Manufacturing And Process Development

    Adam Levy

    Executive Vice President Investor Relations And Corporate Communications

    Frequently Asked Questions regarding Ziopharm Oncology

    • Where are Ziopharm Oncology's Headquarters?

      Ziopharm Oncology's Headquarters are in 1 First Avenue ,Boston,Massachusetts,United States

    • What is Ziopharm Oncology's phone number?

      Ziopharm Oncology's phone number is +1 617-259-1970

    • What is Ziopharm Oncology's stock symbol?

      Ziopharm Oncology's stock symbol is ZIOP

    • What is Ziopharm Oncology's official website?

      Ziopharm Oncology's official website is https://www.ziopharm.com

    • What is Ziopharm Oncology's Revenue?

      Ziopharm Oncology's revenue is $10 - 50M

    • What is Ziopharm Oncology's NAICS code?

      Ziopharm Oncology's NAICS code is 541715

    • How many employees are working in Ziopharm Oncology

      Ziopharm Oncology has 113 employees

    • What is Ziopharm Oncology's Industry?

      Ziopharm Oncology is in the industry of Pharmaceuticals

    Company Directory